Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1997-6-12
pubmed:abstractText
The modifying effect of dietary administration of a xanthine oxidase inhibitor 1'-acetoxychavicol acetate (ACA) present in an edible plant Languas galanga in Thailand on the development of azoxymethane (AOM)-induced colonic aberrant crypt foci (ACF) was investigated in rats. Male F344 rats were given s.c. injections of AOM (15 mg/kg body wt) once a week for 3 weeks to induce colonic ACF. They were fed the diets containing 100 or 200 ppm ACA for 5 weeks, starting 1 week before the first dosing of AOM. At the termination of the study (week 5), AOM induced 118 +/- 28 ACF/colon. Dietary administration of ACA caused significant reduction in the frequency of ACF (41% inhibition by 100 ppm ACA feeding and 37% inhibition by 200 ppm ACA feeding, P<0.01). Such inhibition might be associated with suppression of the proliferation biomarkers' expression such as ornithine decarboxylase activity in the colonic mucosa, number of silver-stained nucleolar organizer regions' protein in the colonic mucosal cell nuclei and blood polyamine content. These results indicate that ACA could inhibit the development of AOM-induced ACF through its suppression of cell proliferation in the colonic mucosa and ACA might be a possible chemopreventive agent against colon tumourigenesis.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0143-3334
pubmed:author
pubmed:issnType
Print
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1113-8
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:9163704-Animals, pubmed-meshheading:9163704-Antineoplastic Agents, pubmed-meshheading:9163704-Azoxymethane, pubmed-meshheading:9163704-Benzyl Alcohols, pubmed-meshheading:9163704-Body Weight, pubmed-meshheading:9163704-Cell Division, pubmed-meshheading:9163704-Colon, pubmed-meshheading:9163704-Colonic Diseases, pubmed-meshheading:9163704-Enzyme Inhibitors, pubmed-meshheading:9163704-Intestinal Mucosa, pubmed-meshheading:9163704-Liver, pubmed-meshheading:9163704-Male, pubmed-meshheading:9163704-Organ Size, pubmed-meshheading:9163704-Ornithine Decarboxylase, pubmed-meshheading:9163704-Polyamines, pubmed-meshheading:9163704-Precancerous Conditions, pubmed-meshheading:9163704-Rats, pubmed-meshheading:9163704-Rats, Inbred F344, pubmed-meshheading:9163704-Terpenes, pubmed-meshheading:9163704-Xanthine Oxidase
pubmed:year
1997
pubmed:articleTitle
A xanthine oxidase inhibitor 1'-acetoxychavicol acetate inhibits azoxymethane-induced colonic aberrant crypt foci in rats.
pubmed:affiliation
First Department of Pathology, Gifu University School of Medicine, Tsukasa-machi, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't